Established in 1998, Sunzen was an animal health care group in the early years. Due to bottlenecks in development, it gradually diversified into businesses such as bird's nest processing, palm oil trade, and human health care in the later stages. Not only did multiple acquisitions not help improve performance, but on the contrary, there were even greater losses and disrespectful performance
Until a new management team joined, the group's business ushered in various aspects of restructuring, such as directly eliminating the palm oil trading business, which had been losing money for many years, and gradually reducing the proportion of animal health services. At the same time, it acquired Finsource Group in 2021 and entered financial loans and education services. Since then, its performance has improved very clearly
It turned a loss into a profit for two consecutive fiscal years. Last year's net profit performance surpassed a new high since listing, thanks to contributions from the human health, bird's nest, and financial loan businesses
According to the latest interview, the Group's next goal is to completely eliminate the animal health business, increase its business contribution to human health care and bird's nest exports, and set a target of at least 100% growth every year. A number of peer acquisitions are currently being discussed, gradually shifting the business model from B2B to B2C, and making good use of existing plant resources to achieve more OBM production. In terms of bird's nest, the Group has now reached an export volume of 7 tons. As China's demand for bird's nest increases, the export volume is expected to reach 18 tons within the next 3 years
Sunzen is a publicly traded company that has successfully transformed in the past two years, and management's foresight is the biggest key
Follow me so you can use it as fast as possible...